Literature DB >> 20110002

The FDA's critical path initiative: a brief introduction.

Stephen Joel Coons.   

Abstract

Mesh：

Year:  2009        PMID： 20110002     DOI： 10.1016/j.clinthera.2009.11.035

Source DB:  PubMed          Journal:  Clin Ther        ISSN： 0149-2918            Impact factor:   3.393


× No keyword cloud information.
  11 in total

1.  Analysis of a urinary biomarker panel for incident kidney disease and clinical outcomes.

Authors:  Conall M O'Seaghdha; Shih-Jen Hwang; Martin G Larson; James B Meigs; Ramachandran S Vasan; Caroline S Fox
Journal:  J Am Soc Nephrol       Date:  2013-08-29       Impact factor: 10.121

2.  Trefoil factor 3 predicts incident chronic kidney disease: a case-control study nested within the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Brad C Astor; Anna Köttgen; Shih-Jen Hwang; Nrupen Bhavsar; Caroline S Fox; Josef Coresh
Journal:  Am J Nephrol       Date:  2011-08-09       Impact factor: 3.754

3.  Association of Urinary Biomarkers of Kidney Injury with Estimated GFR Decline in HIV-Infected Individuals following Tenofovir Disoproxil Fumarate Initiation.

Authors:  Simon B Ascher; Rebecca Scherzer; Michelle M Estrella; William R Zhang; Anthony N Muiru; Vasantha Jotwani; Carl Grunfeld; Chirag R Parikh; Deborah Gustafson; Mary Young; Anjali Sharma; Mardge H Cohen; Derek K Ng; Frank J Palella; Mallory D Witt; Ken Ho; Michael G Shlipak
Journal:  Clin J Am Soc Nephrol       Date:  2018-08-28       Impact factor: 8.237

4.  Proteins Associated with Risk of Kidney Function Decline in the General Population.

Authors:  Morgan E Grams; Aditya Surapaneni; Jingsha Chen; Linda Zhou; Zhi Yu; Diptavo Dutta; Paul A Welling; Nilanjan Chatterjee; Jingning Zhang; Dan E Arking; Teresa K Chen; Casey M Rebholz; Bing Yu; Pascal Schlosser; Eugene P Rhee; Christie M Ballantyne; Eric Boerwinkle; Pamela L Lutsey; Thomas Mosley; Harold I Feldman; Ruth F Dubin; Peter Ganz; Hongzhe Lee; Zihe Zheng; Josef Coresh
Journal:  J Am Soc Nephrol       Date:  2021-09       Impact factor: 14.978

5.  Tenofovir disoproxil fumarate initiation and changes in urinary biomarker concentrations among HIV-infected men and women.

Authors:  William R Zhang; Rebecca Scherzer; Michelle M Estrella; Simon B Ascher; Anthony Muiru; Vasantha Jotwani; Carl Grunfeld; Chirag R Parikh; Deborah Gustafson; Seble Kassaye; Anjali Sharma; Mardge Cohen; Phyllis C Tien; Derek K Ng; Frank J Palella; Mallory D Witt; Ken Ho; Michael G Shlipak
Journal:  AIDS       Date:  2019-03-15       Impact factor: 4.177

6.  Trefoil Factor 1 Excretion Is Increased in Early Stages of Chronic Kidney Disease.

Authors:  Diana Lebherz-Eichinger; Bianca Tudor; Hendrik J Ankersmit; Thomas Reiter; Martin Haas; Franziska Roth-Walter; Claus G Krenn; Georg A Roth
Journal:  PLoS One       Date:  2015-09-21       Impact factor: 3.240

7.  Increased trefoil factor 2 levels in patients with chronic kidney disease.

Authors:  Diana Lebherz-Eichinger; Bianca Tudor; Hendrik J Ankersmit; Thomas Reiter; Martin Haas; Elisa Einwallner; Franziska Roth-Walter; Claus G Krenn; Georg A Roth
Journal:  PLoS One       Date:  2017-03-29       Impact factor: 3.240

8.  Urine Trefoil Factors as Prognostic Biomarkers in Chronic Kidney Disease.

Authors:  Toshio Yamanari; Hitoshi Sugiyama; Keiko Tanaka; Hiroshi Morinaga; Masashi Kitagawa; Akifumi Onishi; Ayu Ogawa-Akiyama; Yuzuki Kano; Koki Mise; Yasukazu Ohmoto; Kenichi Shikata; Jun Wada
Journal:  Biomed Res Int       Date:  2018-04-03       Impact factor: 3.411

9.  Future detection and monitoring of diabetes may entail analysis of both β-cell function and volume: how markers of β-cell loss may assist.

Authors:  Anita V Neutzsky-Wulff; Kim V Andreassen; Sara T Hjuler; Michael Feigh; Anne-Christine Bay-Jensen; Qinlong Zheng; Kim Henriksen; Morten A Karsdal
Journal:  J Transl Med       Date:  2012-10-30       Impact factor: 5.531

10.  Use of Bayesian multivariate meta-analysis to estimate the HAQ for mapping onto the EQ-5D questionnaire in rheumatoid arthritis.

Authors:  Sylwia Bujkiewicz; John R Thompson; Alex J Sutton; Nicola J Cooper; Mark J Harrison; Deborah P M Symmons; Keith R Abrams
Journal:  Value Health       Date:  2014 Jan-Feb       Impact factor: 5.725
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.